No Direct Evidence of Ammonia Elevation from These Psychiatric Medications
None of the medications you listed—quetiapine (Seroquel), buspirone (BuSpar), olanzapine, citalopram, or sertraline (Zoloft)—are recognized causes of hyperammonemia based on current guidelines and FDA labeling. These drugs do not appear in established lists of medications that cause elevated ammonia levels.
Evidence Review
What Actually Causes Drug-Induced Hyperammonemia
The available guidelines on hyperammonemia consistently identify valproic acid as the primary medication culprit for drug-induced ammonia elevation 1. The consensus guidelines specifically state that "hyperammonaemia due to secondary inhibition of the urea cycle occurs in the context of other congenital metabolic abnormalities (such as organic acidaemias), following exposure to certain drugs (such as valproic acid) and in various liver diseases" 1.
The Quetiapine-Valproate Interaction Caveat
There is one important exception worth noting: A case report documented hyperammonemia in patients receiving the combination of valproic acid and quetiapine 2. However, this appears to be an interaction effect where valproic acid (the known ammonia-elevating agent) may have its toxicity potentiated by quetiapine, rather than quetiapine independently causing hyperammonemia. The authors themselves note "a possible risk of hyperammonemia can result from a combination of valproic acid and quetiapine, however further studies are yet needed to confirm this hypothesis" 2.
FDA Labeling and Safety Data
The FDA labeling for Seroquel (quetiapine) does not list hyperammonemia or elevated ammonia levels among its warnings, precautions, or adverse effects 3. The extensive safety profile includes metabolic effects, cardiovascular concerns, and neurological risks, but ammonia elevation is notably absent.
Similarly, SSRIs like citalopram and sertraline have well-characterized safety profiles that do not include hyperammonemia 4, 5.
Clinical Implications
When to Suspect These Medications
If you're evaluating a patient with elevated ammonia on any of these five medications:
- First, look for liver disease: Hepatic encephalopathy guidelines emphasize that psychoactive medications can precipitate hepatic encephalopathy in patients with existing liver dysfunction 6, but this is different from directly causing hyperammonemia
- Check for valproic acid co-administration: If quetiapine or olanzapine is combined with valproate, this interaction deserves consideration 2
- Consider alternative causes: Urea cycle disorders, organic acidemias, acute liver injury, or other hepatotoxic medications are far more likely culprits 1
The Hepatic Encephalopathy Context
Guidelines on hepatic encephalopathy list "psychoactive medication" as a precipitating factor for HE 6, but this refers to CNS depression that can unmask or worsen encephalopathy in patients with pre-existing liver disease and baseline ammonia handling problems—not to these drugs independently raising ammonia levels in patients with normal liver function.
Bottom Line
These five psychiatric medications are not ammonia-elevating drugs. If a patient on these medications develops hyperammonemia, investigate standard causes: liver disease, valproic acid exposure (especially with quetiapine), urea cycle disorders, or other metabolic derangements. Do not attribute the ammonia elevation to buspirone, the SSRIs (citalopram, sertraline), or the atypical antipsychotics (quetiapine, olanzapine) as monotherapy.